RPRD Diagnostics announced a collaboration with Children’s Minnesota dedicated to implementing a pharmacogenomic testing process. … By implementing this process the aim is to ensure patients get the right medication at the right time, making care more precise and more affordable.

To meet the growing demand for preemptive pharmacogenomic risk factor screening that may one day aid drug prescription practices, Thermo Fisher Scientific today introduced PharmacoScan Solution, a new microarray-based research tool that contains pharmacogenomic content with relevant markers involved in absorption, distribution, metabolism and excretion (ADME) pathways of commonly prescribed medicines.